Experience gathered from retrospective series on renal cell carcinoma is useful, but now it is time for a global claim for academically driven prospective studies

MeSH terms

• Angiogenesis Inhibitors / therapeutic use*
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Carcinoma, Renal Cell / drug therapy*
• Carcinoma, Renal Cell / secondary*
• Female
• Humans
• Kidney Neoplasms / drug therapy*
• Kidney Neoplasms / pathology*
• Male
• Molecular Targeted Therapy*
• Protein Kinase Inhibitors / therapeutic use*